Menu Search
Equities

Atrys Health SA

ATRY:MCE

Atrys Health SA

Actions
  • Price (EUR)3.13
  • Today's Change-0.03 / -0.95%
  • Shares traded93.99k
  • 1 Year change-15.63%
  • Beta0.3456
Data delayed at least 15 minutes, as of Nov 08 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Atrys Health SA had net income fall 96.96% from a loss of 23.15m to a larger loss of 45.59m despite a 27.28% increase in revenues from 158.37m to 201.57m. An increase in the cost of goods sold as a percentage of sales from 20.44% to 29.67% was a component in the falling net income despite rising revenues.
Gross margin66.90%
Net profit margin-18.01%
Operating margin-3.74%
Return on assets-5.29%
Return on equity-11.57%
Return on investment-6.29%
More ▼

Cash flow in EURView more

In 2023, Atrys Health SA increased its cash reserves by 21.97%, or 7.53m. Cash Flow from Financing totalled 8.19m or 4.06% of revenues. In addition the company used 1.09m for operations while cash from investing totalled 395.00k.
Cash flow per share-0.059
Price/Cash flow per share--
Book value per share3.57
Tangible book value per share-2.15
More ▼

Balance sheet in EURView more

Atrys Health SA has a Debt to Total Capital ratio of 48.01%, a lower figure than the previous year's 55.99%.
Current ratio0.9789
Quick ratio0.9623
Total debt/total equity0.923
Total debt/total capital0.4801
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.